Search

Search Results

• 

  Vorapaxar

  Gianluca Airoldi, Mauro Campanini

  88-95

  24-04-2013

  https://doi.org/10.4081/itjm.2013.88

  1226

  PDF: 684

  HTML: 221
• 

  Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

  Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale

  314-322

  15-12-2015

  https://doi.org/10.4081/itjm.2015.468

  2000

  PDF: 944

  HTML: 1242
• 

  Dabigatran etexilate: a direct thrombin inhibitor

  M. Dugnani

  56-62

  03-05-2013

  https://doi.org/10.4081/itjm.2007.3.56

  953

  PDF: 1511

• Assessment and predictors of inappropriate dose of direct oral anticoagulants

  Mosaad O. Almegren

  09-01-2024

  https://doi.org/10.4081/itjm.2024.1679

  1000

  pdf: 504

  HTML: 140
• 

  Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics

  Luca Masotti, Mauro Campanini

  1-7

  24-12-2013

  https://doi.org/10.4081/itjm.2013.s8.1

  11905

  PDF: 2997
• 

  A review on management of antiphospholipid syndrome in clinical practice

  Carmine Siniscalchi, Pietro Rossetti, Gaetano Carolla, Pierpaolo Di Micco, Adriano Stella, Michele Riva

  13-09-2023

  https://doi.org/10.4081/itjm.2023.1649

  2808

  PDF: 1152

  HTML: 82
• 

  The erectile dysfunction as a cardiovascular risk factor

  Nathan Artom, Giuliano Pinna

  210-220

  04-12-2014

  https://doi.org/10.4081/itjm.2014.500

  1619

  PDF: 894

  HTML: 1543
• 

  Pregnancy and heart disease: what Internists should know

  Riccardo Gerloni, Domenico Panuccio

  288-304

  11-09-2017

  https://doi.org/10.4081/itjm.2017.815

  1452

  PDF: 731

  HTML: 270
• 

  Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

  Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, Niccolò Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli

  153-169

  23-10-2012

  https://doi.org/10.4081/itjm.2012.153

  1711

  PDF: 2039
• 

  A dangerous adverse event in the use of dabigatran

  Manuel Monti, Giovanni Maria Vincentelli, Francesco Borgognoni, Giuseppe Murdolo, Feliciano Menghini

  250-251

  09-11-2015

  https://doi.org/10.4081/itjm.2015.629

  1631

  PDF: 932

  HTML: 254
• 

  Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry

  Luca Masotti, Rinaldo Innocenti, Stefano Spolveri, Irene Chiti, Grazia Panigada, Cristiana Seravalle, Giancarlo Landini, Alberto Fortini, Rino Migliacci, Raffaele Laureano, for Tuscan FADOI Stroke Registry Investigators

  134-140

  12-06-2014

  https://doi.org/10.4081/itjm.2014.450

  1642

  PDF: 1272

  Appendix: 584

  HTML: 622
• 

  How artificial intelligence during the pandemic modified the role of a biomarker as d-dimer

  Pierpaolo Di Micco, Francesca Futura Bernardi, Giovanni Maria Fusco, Alessandro Perrella

  20-11-2023

  https://doi.org/10.4081/itjm.2023.1656

  1061

  PDF: 388

  HTML: 30